Novo Nordisk A/S (NVO)
FlaggedUS listed · Healthcare · Drug Manufacturers - General
This page tracks Novo Nordisk A/S (NVO) with live price data, technical indicators (RSI, MACD, moving averages, Sharpe ratio), and AI-powered analysis. Our scanner continuously reviews NVO against ~5,000 North American equities — fusing market fundamentals with frontier AI to surface high-conviction opportunities before they break out.
New to these indicators? RSI, MACD, and moving averages explained — plus how AI forecasting works.
Latest AI Analysis
Updated Sep 11, 2026Screen strength 6.6The STRONG_SELL pre-screen is substantially confirmed by a -1.06 Sharpe ratio, -43.61% 1Y CAGR, and a bearish technical posture (price below both declining moving averages, negative MACD histogram, RSI 36 trending lower). However, today's volume collapsed to 0.19x average on a -1.23% move, which reduces conviction in the immediate downside thrust. The recent Morgan Stanley downgrade ($40 target, 7% downside) and broader bearish consensus on GLP-1 transition risk are material headwinds, but the stock is already down sharply (from $409 in the 52-week high), creating a potential capitulation wash. Verify whether the volume weakness reflects institutional repositioning (bearish) or exhausted selling (potentially constructive for a bounce), and monitor macro sentiment as the Fear & Greed index at 34 suggests broader market stress may be a larger driver than NVO-specific deterioration.
NVO AI Signal Track Record
Recent scanner signals for Novo Nordisk A/S. Each is a point-in-time AI assessment, not a guarantee of future performance.
| Date | Signal | Screen strength | Price at signal |
|---|---|---|---|
| Sep 11, 2026 | Flagged | 6.6 | $42.95 |
| Sep 11, 2026 | Flagged | 6.6 | $42.95 |
| Sep 11, 2026 | Flagged | 6.6 | $42.87 |
| Sep 11, 2026 | Flagged | 6.6 | $43.03 |
NVO — Frequently Asked Questions
Is Novo Nordisk A/S (NVO) a buy right now?
As of September 11, 2026, StockTracker AI's screen flags NVO as Flagged, with a ±2% typical 3-day move, based on its multi-factor technical screen and AI review. This is a technical screen and informational analysis, not financial advice or a recommendation to trade — confirm it against your own research and risk tolerance.
What is NVO's RSI?
NVO's 14-day RSI was 36.2 at the last scan — in neutral territory. RSI above 70 is generally considered overbought and below 30 oversold; the 40–60 band is neutral and is best read alongside trend and momentum rather than on its own.
What is the AI price forecast for NVO?
StockTracker AI generates a probability-weighted 30-day price forecast for NVO — a mathematical baseline (regression on recent prices) adjusted by an AI model for news, earnings proximity, and the current macro regime, with bull/base/bear scenarios. Sign in to generate the latest forecast.
How does StockTracker AI analyze NVO?
Each scan screens NVO on momentum, RSI, MACD, moving-average posture, Sharpe ratio, and 1-year CAGR to build a composite score, then a frontier AI model reviews the full picture — fundamentals, macro context, and recent news — to confirm or challenge the signal before it's surfaced.
Get the full picture for NVO — free.
Add NVO to a watchlist for instant scanner alerts. Run an on-demand 30-day AI price forecast. See the full historical signal track record. Free tier, no credit card.
Related stocks in Healthcare
Get scanner alerts and AI forecasts for NVO
Free tier includes daily AI analysis, charts with indicators, and a 3-stock watchlist. No credit card.
Get Started →